← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-9 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

CD19-CART (CD19-CART)

B Acute Lymphoblastic Leukemia; Mantle Cell Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleBambino Gesù Hospital and Resea…Phase 2

CD19-CAR_Lenti T cell (CD19-CAR_Lenti T cell)

Acute Lymphoblastic Leukemia; Diffuse Large B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBambino Gesù Hospital and Resea…Phase 1

CD19-CAR_Lenti_ALLO (CD19-CAR_Lenti_ALLO)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleChulalongkorn UniversityPhase 1

CD19-IL7Ra CAR-T cells (CD19-IL7Ra CAR-T cells)

Relapse B Acute Lymphoblastic Leukemia; Refactory Childhood Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleChinese PLA General HospitalPhase 2

CD19-PD1-CART Cell (CD19-PD1-CART Cell)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleTimmune Biotech Inc.Phase 1

CD19-TriCAR-T (CD19-TriCAR-T)

Non-hodgkin Lymphoma,B Cell · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleSecond Military Medical Univers…Phase 2

CD19-specific chimeric antigen receptor (CD19-specific chimeric antigen receptor)

Recurrent B-Cell Tumor; Refractory B-Cell Tumor · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 1

CD19-targetd CAR-T (CD19-targetd CAR-T)

Juvenile Dermatomyositis · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleFuda Cancer Hospital, GuangzhouPhase 2

CD19-targeting CAR T Cells infusion (CD19-targeting CAR T Cells infusion)

B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleUniversity of Maryland, Baltimo…Phase 1

CD19.20.22 CAR T cells (CD19.20.22 CAR T cells)

B-Cell Lymphoma; Diffuse Large B Cell Lymphoma (DLBCL) · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-CD28Z T Cells - dose escalation 1 (CD19.CAR-CD28Z T Cells - dose escalation 1)

Non-Hodgkin's Lymphoma; B-Cell ALL · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-CD28Z T Cells - dose escalation 2 (CD19.CAR-CD28Z T Cells - dose escalation 2)

Non-Hodgkin's Lymphoma; B-Cell ALL · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-aNKT cells (CD19.CAR-aNKT cells)

Refractory B-Cell Non-Hodgkin Lymphoma; Refractory B-Cell Small Lymphocytic Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-multiVST for Group A (CD19.CAR-multiVST for Group A)

Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-multiVST for Group B (CD19.CAR-multiVST for Group B)

Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
CGTBiologicstaleThe First Affiliated Hospital o…Phase 2

CD19/22 CART (CD19/22 CART)

Relapsed Non Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleChanghai HospitalPhase 1

CD19/BCMA CAR NK (CD19/BCMA CAR NK)

IgG4 Related Disease · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleYihao WangPhase 2

CD19/BCMA CAR-T (CD19/BCMA CAR-T)

Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleUnion Hospital, Tongji Medical …Phase 1

CD19/BCMA CAR-T cell therapy (CD19/BCMA CAR-T cell therapy)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleYake Biotechnology Ltd.Phase 1

CD19/BCMA Targeted CAR T-cells and dasatinib (CD19/BCMA Targeted CAR T-cells and dasatinib)

Multiple Myeloma in Relapse; Multiple Myeloma, Refractory · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING

104 / 209 페이지

← 이전다음 →